Radiopharm Theranostics Limited (ASX:RAD)
Australia · Delayed Price · Currency is AUD 0.0190
-0.0010 (-5.00%)
Jul 10, 2026, 4:10 PM AEST
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of 67.34 million as of July 10, 2026. Its market cap has increased by 23.80% in one year.
Market Cap
67.34M
Enterprise Value
30.98M
Revenue
16.28M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from 101.33M to 67.34M, a decrease of -33.55%. That is a compound annual growth rate of -8.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 67.34M | -24.00% |
| Dec 31, 2025 | 88.61M | 68.31% |
| Dec 31, 2024 | 52.65M | 91.43% |
| Dec 29, 2023 | 27.50M | -20.28% |
| Dec 30, 2022 | 34.50M | -65.53% |
| Dec 31, 2021 | 100.07M | -1.25% |
| Nov 25, 2021 | 101.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nyrada | 102.88M |
| Paradigm Biopharmaceuticals | 89.33M |
| Avecho Biotechnology | 88.10M |
| Immutep | 81.05M |
| Arovella Therapeutics | 80.99M |
| Prescient Therapeutics | 78.86M |
| Amplia Therapeutics | 71.86M |
| Botanix Pharmaceuticals | 65.62M |